US 10144930
Inhibitors of MYH7B and uses thereof
granted A61KA61K2300/00A61K31/7105
Quick answer
US patent 10144930 (Inhibitors of MYH7B and uses thereof) held by MIRAGEN THERAPEUTICS, INC. expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MIRAGEN THERAPEUTICS, INC.
- Grant date
- Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2300/00, A61K31/7105, A61K31/713, A61K45/06